NewYork-Presbyterian/Columbia University Medical Center released the outcomes of a study that gives heart and circulatory system doctors the chance to feel better about giving aspirin to patients who've had heart failure are are taking blood thinners.
The 10-year experiment involved giving those who have had heart failure and took angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) as an initial medicine and then either aspirin or warfarin, a NewYork-Presbyterian Hospital release said.
The study, called the Warfarin and Aspirin for Reduced Cardiac Ejection Fraction (WARCEF) study, was set up so that neither the medical experts nor the people taking part in the experiment knew who would be getting aspirin or warfarin. The study involved 2,305 people who have had heart failure and now have less oxygen-filled blood going to the body from the heart, the release said.
The results of the study showed that both aspirin and warfarin caused the same level of risk of returning to the hospital or dying of heart related causes, the release said.
Other heart studies have shown that aspirin and medicines designed for heart failure may not be good together.
